NuvaRing sistem cu cedare vaginala 11,7 mg + 2,7 mg Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

nuvaring sistem cu cedare vaginala 11,7 mg + 2,7 mg

schering-plough central east ag - etonogestrelum + ethinylestradiolum - sistem cu cedare vaginala - 11,7 mg + 2,7 mg

Rebetol capsule 200 mg Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

rebetol capsule 200 mg

schering-plough central east ag - ribavirinum - capsule - 200 mg

Singulair comprimate filmate 10 mg Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

singulair comprimate filmate 10 mg

schering-plough central east ag - montelukastum - comprimate filmate - 10 mg

Singulair comprimate masticabile 4 mg Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

singulair comprimate masticabile 4 mg

schering-plough central east ag - montelukastum - comprimate masticabile - 4 mg

Singulair comprimate masticabile 5 mg Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

singulair comprimate masticabile 5 mg

schering-plough central east ag - montelukastum - comprimate masticabile - 5 mg

AVELOX- moxifloxacin hydrochloride injection, solution AVELOX- moxifloxacin hydrochloride tablet, film coated Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

avelox- moxifloxacin hydrochloride injection, solution avelox- moxifloxacin hydrochloride tablet, film coated

schering plough corporation - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin 400 mg in 250 ml - avelox is indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies (14.3 )] . mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. avelox is indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies (14.4 )]. avelox is indicated in adult patients for the treatment of complicated skin and ski

Claritine sirop 1 mg/ml Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

claritine sirop 1 mg/ml

schering-plough central east ag - loratadinum - sirop - 1 mg/ml

Diprospan suspensie injectabila 2,63 mg + 6,43 mg/ml Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

diprospan suspensie injectabila 2,63 mg + 6,43 mg/ml

schering-plough central east ag - betamethasoni natrii phosphas + betamethasoni dipropionas - suspensie injectabila - 2,63 mg + 6,43 mg/ml

Cedax capsule 400 mg Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

cedax capsule 400 mg

schering-plough central east ag - ceftibutenum - capsule - 400 mg

Cedax pulbere pentru suspensie orala 36 mg/ml Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

cedax pulbere pentru suspensie orala 36 mg/ml

schering-plough central east ag - ceftibutenum - pulbere pentru suspensie orala - 36 mg/ml